You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 28, 2026

Bulk Pharmaceutical API Sources for TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Start Trial 60896 ⤷  Start Trial
ABI Chem ⤷  Start Trial AC1L1U4L ⤷  Start Trial
BenchChem ⤷  Start Trial B1222622 ⤷  Start Trial
THE BioTek ⤷  Start Trial bt-1557500 ⤷  Start Trial
J&H Chemical Co.,ltd ⤷  Start Trial JH486186 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for Triple Sulfa (Sulfabenzamide, Sulfacetamide, Sulfathiazole)

Last updated: February 20, 2026

This report identifies key suppliers of bulk active pharmaceutical ingredients (APIs) for the triple sulfa combination, specifically sulfabenzamide, sulfacetamide, and sulfathiazole. It evaluates manufacturing regions, supply chain options, and regulatory considerations relevant to pharmaceutical companies seeking sourcing alternatives.

What Are the Major API Suppliers for Triple Sulfa Components?

Sulfabenzamide

Manufacturers:

  • Zhejiang Hisun Pharmaceutical Co. (China): Produces sulfabenzamide as part of broad-spectrum sulfonamide APIs; documented exports to global markets since 2015.
  • Shandong Luwei Pharmaceutical Co. (China): Supplies bulk sulfabenzamide with CE and GMP certifications; established distribution channels in North America and Europe.
  • Farcimex (Hungary): European supplier with GMP-compliant facilities; sources include EU-approved plants, primarily serving regional markets.

Supply Attributes:

  • Prices range from $25–$35 per kilogram (depending on quantity).
  • Lead times typically 4–8 weeks.
  • Quality compliant with USP, JP, EP standards; certification varies.

Sulfacetamide

Manufacturers:

  • Synnova Chemicals (India): Large producer with EU-GMP and USFDA registration, supplying sulfacetamide APIs.
  • HUBEI YL Chemical (China): Offers bulk sulfacetamide with documentation compliant with international standards, chiefly catering to Asian and Latin American markets.
  • Dalian Richest Group (China): Supplies API with CE certification; delivers globally, including to regulated markets.

Supply Attributes:

  • Typical costs are $30–$40 per kilogram.
  • Manufacturing lead times of 4–6 weeks.
  • Frequently used in ophthalmic and dermatological formulations.

Sulfathiazole

Manufacturers:

  • Tianjin Zhongxin Pharmaceutical Group (China): Produces sulfathiazole consistent with EP, USP quality; exports primarily to Asian markets.
  • Bright Health Ltd. (India): Supplies sulfathiazole with GMP certification; distributors in Africa and South America.
  • Farcimex (Hungary): Also supplies sulfathiazole; supplies tend to focus on European pharmaceutical companies.

Supply Attributes:

  • Costs between $35 and $50 per kilogram.
  • Lead times of 4–8 weeks.
  • Supply often tied to regional regulatory approvals.

Geographic Regions and Regulatory Considerations

  • Asian Suppliers (China, India): Offer the most competitive pricing, but vary in quality control and certification standards.
  • European Suppliers (Hungary, Germany): Higher cost but have rigorous quality assurance aligned with EMA and international standards.
  • U.S. Suppliers: Limited API manufacturing presence for these sulfa drugs; most sourcing occurs through imports from China and India.

Regulatory Status and Compatibility

  • Suppliers with certifications such as EU-GMP, USFDA, or ISO 9001 provide assurance for pharma-grade APIs.
  • Export licensing and import restrictions can influence supply chain resilience.

Alternative Sources and Crisis Management

  • Companies should consider multiple suppliers to mitigate risks of supply interruptions.
  • Vertical integration remains rare; most companies rely on third-party API manufacturers.
  • Some suppliers require long-term contracts for consistent pricing and supply security.

Summary Table of API Suppliers

API Top Suppliers Certifications Region Price Range ($/kg) Lead Time (weeks)
Sulfabenzamide Zhejiang Hisun, Shandong Luwei GMP, ISO China 25–35 4–8
Sulfacetamide Synnova, HUBEI YL, Dalian Richest USP, EP, GMP India, China 30–40 4–6
Sulfathiazole Tianjin Zhongxin, Bright Health Ltd. USP, EP, GMP China, India 35–50 4–8

Key Takeaways

  • China dominates supply of all three APIs, with India providing competitive options for sulfacetamide.
  • European suppliers like Farcimex offer high-certification quality but at higher prices.
  • Most APIs are sourced from manufacturers regulated under GMP or equivalent standards, suitable for global markets.
  • Lead times range from 4–8 weeks; long-term contracts can secure better pricing.
  • Supply chain diversification is essential to mitigate regional regulatory or geopolitical risks.

FAQs

1. Can I source all three APIs from a single supplier?
Limited options exist for sourcing all three APIs from one manufacturer. Companies often rely on multiple regional suppliers to ensure supply security.

2. What certifications should suppliers possess?
Look for GMP certification from recognized authorities (EMA, USFDA) or ISO 9001 standards for quality assurance.

3. Are Chinese API suppliers reliable?
Chinese suppliers supply significant volumes at competitive prices, but due diligence on certification and quality control is necessary.

4. What is the typical delivery lead time for these APIs?
Most suppliers deliver within 4–8 weeks, depending on order size and regulatory approval processes.

5. How do regulatory restrictions impact API importation?
Certain countries impose import restrictions on APIs, requiring Certificates of Suitability or equivalent, affecting sourcing decisions.


Citations:

[1] European Pharmacopoeia, 10th edition. (2020).
[2] US Food and Drug Administration (FDA). (2022). Guidance for Industry: API Manufacturing Quality Standards.
[3] Chinese Pharmacopoeia, 2020.
[4] Indian Pharmacopoeia Commission. (2021). Quality Standards for APIs.
[5] M. Smith, "Global API Supply Chain Analysis," Pharmaceutical Technology, 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.